Novartis AG
Symbol: NVS (NYSE)
130.74
▼ (-0.68%) -0.899
Company Description:
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.
Key Stats
- Today's Open: $131.53
- Today's High: $132.296
- Today's Low: $130.298
- Today's Volume: 852.87K
- Yesterday Close: $131.64
- Yesterday High: $131.68
- Yesterday Low: $130.62
- Yesterday Volume: 1.67M
- Last Min Volume: 2.16K
- Last Min High: $130.735
- Last Min Low: $130.707
- Last Min VWAP: $130.72461
Company Profile
- Name: Novartis AG
- Website: https://www.novartis.com
- Listed Date: 1996-11-07
- Location: ,
- Market Status: Active
- CIK Number: 0001114448
- SIC Code:
- SIC description:
- Market Cap: $254.84B
- Round Lot: 100
- Outstanding Shares: 1.94B
- Asset Type: ADRC
RECENT FILINGS FOR NVS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-22 | SC TO-T/A | View |
| 2025-10-20 | SC TO-T/A | View |
| 2025-09-30 | 6-K | View |
| 2025-09-29 | SC TO-T | View |
| 2025-09-09 | SC TO-C | View |
| 2025-08-11 | 6-K | View |
| 2025-07-17 | 6-K | View |
| 2025-07-17 | SCHEDULE 13G | View |
| 2025-07-17 | 6-K | View |
| 2025-06-25 | SC TO-T/A | View |
| 2025-06-23 | SC TO-T/A | View |
| 2025-06-17 | SC TO-T/A | View |
| 2025-06-02 | 6-K | View |
| 2025-05-27 | SC TO-T | View |
| 2025-05-23 | 144 | View |
| 2025-05-01 | SC TO-C | View |
| 2025-04-30 | SC TO-C | View |
| 2025-04-30 | 144 | View |
| 2025-04-29 | 6-K | View |
| 2025-04-08 | UPLOAD | View |